Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/104666

In Collections

This item can be found in the following collections:

Reichardt, P.; Demetri, G.D.; Jeffers, M.; Kang, Y.K.; Blay, J.Y.; Rutkowski, P.; ... ; Casali, P.G. (2014)

Mutational analysis of plasma DNA from patients (pts) in the phase III GRID study of regorafenib (REG) versus placebo (PL) in tyrosine kinase inhibitor (TKI)-refractory GIST: Correlating genotype with clinical outcomes

Article / Letter to editor
All authors
Reichardt, P.; Demetri, G.D.; Jeffers, M.; Kang, Y.K.; Blay, J.Y.; Rutkowski, P.; Gelderblom, H.; Hohenberger, P.; Leahy, M.G.; Mehren, M. von; Joensuu, H.; Badalamenti, G.; Blackstein, M.E.; Cesne, A. le; Schoffski, P.; Maki, R.G.; Xu, J.M.; Nishida, T.; Kuss, I.; Casali, P.G.
Date
2014-02-28
Journal
Oncology Research and Treatment
Volume
37
Pages
58 - 58